A citation-based method for searching scientific literature

Jia Zhang, Zhilong Zhao, Jiansheng Wang. World J Surg Oncol 2014
Times Cited: 11







List of co-cited articles
68 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Five cardiac hormones decrease the number of human small-cell lung cancer cells.
B A Vesely, S Song, J Sanchez-Ramos, S R Fitz, A A Alli, S M Solivan, W R Gower, D L Vesely. Eur J Clin Invest 2005
47
36

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.
Alan S Maisel, Padma Krishnaswamy, Richard M Nowak, James McCord, Judd E Hollander, Philippe Duc, Torbjørn Omland, Alan B Storrow, William T Abraham, Alan H B Wu,[...]. N Engl J Med 2002
36

Natriuretic peptide receptor a as a novel anticancer target.
Xiaoyuan Kong, Xiaoqin Wang, Weidong Xu, Sumita Behera, Gary Hellermann, Arun Kumar, Richard F Lockey, Subhra Mohapatra, Shyam S Mohapatra. Cancer Res 2008
52
27

Natriuretic peptides.
Lori B Daniels, Alan S Maisel. J Am Coll Cardiol 2007
722
27

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.
J Gosling, S Slaymaker, L Gu, S Tseng, C H Zlot, S G Young, B J Rollins, I F Charo. J Clin Invest 1999
539
27

High N-terminal pro-B-type natriuretic peptide: a biomarker of lung cancer?
Nathalie Aujollet, Marjorie Meyer, Romain Cailliod, Fanny Combier, Yann Coignet, Sebastien Campard, Olivier Facy, Alain Bernard, Claude Girard. Clin Lung Cancer 2010
10
30

Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells.
Neil J Manimala, Chelsea D Frost, Meghan L Lane, Mariana Higuera, Rana Beg, David L Vesely. Eur J Clin Invest 2013
13
27

Cancer patients with markedly elevated B-type natriuretic peptide may not have volume overload.
Sukesh C Burjonroppa, Ann T Tong, Lian-Chun Xiao, Marcella M Johnson, S Wamique Yusuf, Daniel J Lenihan. Am J Clin Oncol 2007
43
27

What is causing extremely elevated amino terminal brain natriuretic peptide in cancer patients?
Jesal Popat, Abel Rivero, Pravin Pratap, Maya Guglin. Congest Heart Fail 2013
17
27

Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.
Dirk J A Lok, Peter Van Der Meer, Pieta W Bruggink-André de la Porte, Erik Lipsic, Jan Van Wijngaarden, Hans L Hillege, Dirk J van Veldhuisen. Clin Res Cardiol 2010
309
27

Usefulness of a combination of monocyte chemoattractant protein-1, galectin-3, and N-terminal probrain natriuretic peptide to predict cardiovascular events in patients with coronary artery disease.
José Tuñón, Luis Blanco-Colio, Carmen Cristóbal, Nieves Tarín, Javier Higueras, Ana Huelmos, Joaquín Alonso, Jesús Egido, Dolores Asensio, Óscar Lorenzo,[...]. Am J Cardiol 2014
48
27

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.
L Gu, Y Okada, S K Clinton, C Gerard, G K Sukhova, P Libby, B J Rollins. Mol Cell 1998
27

NT-proBNP: a cardiac biomarker to assess prognosis in non-Hodgkin lymphoma.
Eva Gimeno, Miquel Gómez, Juan Ramón González, Josep Comín, Alberto Alvarez-Larrán, Blanca Sánchez-González, Lluis Molina, Eva Domingo-Domenech, Francesc Garcia-Pallarols, Carmen Pedro,[...]. Leuk Res 2011
20
27

Galectin-3: an open-ended story.
Jerka Dumic, Sanja Dabelic, Mirna Flögel. Biochim Biophys Acta 2006
721
27

Atrial natriuretic peptide prevents cancer metastasis through vascular endothelial cells.
Takashi Nojiri, Hiroshi Hosoda, Takeshi Tokudome, Koichi Miura, Shin Ishikane, Kentaro Otani, Ichiro Kishimoto, Yasushi Shintani, Masayoshi Inoue, Toru Kimura,[...]. Proc Natl Acad Sci U S A 2015
62
27



Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction.
D G Lowe, M S Chang, R Hellmiss, E Chen, S Singh, D L Garbers, D V Goeddel. EMBO J 1989
349
18

The age of cancer.
R A DePinho. Nature 2000
650
18


Novel dual inhibitors of vascular endothelial growth factor and VEGFR2 receptor.
Jennifer P Nguyen, Chelsea D Frost, Meghan L Lane, William P Skelton, Michelle Skelton, David L Vesely. Eur J Clin Invest 2012
17
18

Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
Torbjørn Omland, Marc A Pfeffer, Scott D Solomon, James A de Lemos, Helge Røsjø, Jūratė Šaltytė Benth, Aldo Maggioni, Michael J Domanski, Jean L Rouleau, Marc S Sabatine,[...]. J Am Coll Cardiol 2013
212
18


N-terminal pro-B-type natriuretic peptide after high-dose chemotherapy: a marker predictive of cardiac dysfunction?
Maria T Sandri, Michela Salvatici, Daniela Cardinale, Laura Zorzino, Rita Passerini, Paola Lentati, Maria Leon, Maurizio Civelli, Giovanni Martinelli, Carlo M Cipolla. Clin Chem 2005
157
18

Diet and cancer.
W C Willett. Oncologist 2000
127
18

Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma.
Robert J Biggar, Julia S Johansen, Karin Ekström Smedby, Klaus Rostgaard, Ellen T Chang, Hans-Olov Adami, Bengt Glimelius, Daniel Molin, Stephen Hamilton-Dutoit, Mads Melbye,[...]. Clin Cancer Res 2008
49
18


Atrial natriuretic peptide and brain natriuretic peptide release in human essential hypertension.
Hayet Soualmia, Ilhem Ayadi, Souheil Omar, Moncef Feki, Habiba Drissa, Abderraouf Mebazaa, Naziha Kaabachi. Clin Lab 2009
12
18

Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study.
Cathrine Wold Knudsen, Torbjørn Omland, Paul Clopton, Arne Westheim, Alan H B Wu, Philippe Duc, James McCord, Richard M Nowak, Judd E Hollander, Alan B Storrow,[...]. J Am Coll Cardiol 2005
117
18

Simultaneous elevation of the serum concentrations of vascular endothelial growth factor and interleukin-6 as independent predictors of prognosis in aggressive non-Hodgkin's lymphoma.
Nozomi Niitsu, Masataka Okamato, Hirokazu Nakamine, Tadashi Yoshino, Jun-ichi Tamaru, Shigeo Nakamura, Masaki Higashihara, Masami Hirano. Eur J Haematol 2002
68
18


Immunoreactive brain natriuretic peptide in human adrenal glands and adrenal tumors.
K Totsune, K Takahashi, O Murakami, F Satoh, M Sone, M Ohneda, Y Miura, T Mouri. Eur J Endocrinol 1996
11
18

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.
Brian F Skinnider, Andrew J Elia, Randy D Gascoyne, Bruce Patterson, Lorenz Trumper, Ursula Kapp, Tak W Mak. Blood 2002
203
18


BNP and NT-proBNP, predictors of 1-year mortality in nursing home residents.
Maaike Barents, Hans H L Hillege, Iwan C C van der Horst, Rudolph A de Boer, J Koster, Frits A J Muskiet, Mike J L de Jongste. J Am Med Dir Assoc 2008
16
18

Human small cell lung cancer cells produce brain natriuretic peptide.
Y Ohsaki, A J Gross, P T Le, H Oie, B E Johnson. Oncology 1999
23
18

Atrial natriuretic peptide modulates the proliferation of human gastric cancer cells via KCNQ1 expression.
Jia Zhang, Zhilong Zhao, Chao Zu, Haijian Hu, Hui Shen, Mingxin Zhang, Jiansheng Wang. Oncol Lett 2013
18
18

Brain natriuretic peptide precursor (NT-pro-BNP) levels predict for clinical benefit to sunitinib treatment in patients with metastatic renal cell carcinoma.
Konstantinos T Papazisis, Lukas F Kontovinis, Christos N Papandreou, George Kouvatseas, Christos Lafaras, Evangelos Antonakis, Maria Christopoulou, Charalambos Andreadis, Despoina Mouratidou, Alexandros H Kortsaris. BMC Cancer 2010
9
22


Clinical relevance of a raised plasma N-terminal pro-brain natriuretic peptide level in a population-based cohort of nonagenarians.
Bert Vaes, Wouter de Ruijter, Jan Degryse, Rudi G J Westendorp, Jacobijn Gussekloo. J Am Geriatr Soc 2009
31
18

Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis.
Luis M Blanco-Colio, Jose L Martín-Ventura, Begoña Muñóz-García, Josune Orbe, Jose A Páramo, Jean-Baptiste Michel, Alberto Ortiz, Olivier Meilhac, Jesús Egido. Arterioscler Thromb Vasc Biol 2007
97
18


Serum interleukin-6 levels correlate with prognosis in diffuse large-cell lymphoma.
J F Seymour, M Talpaz, F Cabanillas, M Wetzler, R Kurzrock. J Clin Oncol 1995
138
18

C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain.
T Sudoh, N Minamino, K Kangawa, H Matsuo. Biochem Biophys Res Commun 1990
933
18

The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system.
N Matsukawa, W J Grzesik, N Takahashi, K N Pandey, S Pang, M Yamauchi, O Smithies. Proc Natl Acad Sci U S A 1999
312
18

Visualization of cGMP with cGi biosensors.
Martin Thunemann, Natalie Fomin, Christian Krawutschke, Michael Russwurm, Robert Feil. Methods Mol Biol 2013
24
18

Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions.
Lincoln R Potter, Sarah Abbey-Hosch, Deborah M Dickey. Endocr Rev 2006
670
18

Sildenafil use and increased risk of incident melanoma in US men: a prospective cohort study.
Wen-Qing Li, Abrar A Qureshi, Kathleen C Robinson, Jiali Han. JAMA Intern Med 2014
73
18

Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approach.
Michael Russwurm, Florian Mullershausen, Andreas Friebe, Ronald Jäger, Corina Russwurm, Doris Koesling. Biochem J 2007
93
18

Cyclic nucleotide research -- still expanding after half a century.
Joseph A Beavo, Laurence L Brunton. Nat Rev Mol Cell Biol 2002
625
18


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.